{{Rsnum
|rsid=2779251
|Chromosome=17
|position=27804300
|Orientation=plus
|GMAF=0.1244
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 26.8 | 70.5
| HCB | 0.7 | 7.3 | 92.0
| JPT | 0.0 | 10.6 | 89.4
| YRI | 1.4 | 28.6 | 70.1
| ASW | 3.5 | 29.8 | 66.7
| CHB | 0.7 | 7.3 | 92.0
| CHD | 0.0 | 8.3 | 91.7
| GIH | 7.0 | 24.0 | 69.0
| LWK | 0.9 | 20.9 | 78.2
| MEX | 5.2 | 13.8 | 81.0
| MKK | 8.3 | 38.5 | 53.2
| TSI | 2.0 | 35.3 | 62.7
| HapMapRevision=28
}}
{{PMID|19074885}} chronic lymphocytic [[leukemia]] [[rs2266690]] [[rs17028658]] [[rs4505265]] [[rs1045485]] [[rs2779251]] [[rs3136687]]

{{PMID Auto
|PMID=19635578
|Title=NO role of NOS2A susceptibility polymorphisms in rheumatoid arthritis
}}

{{PMID Auto
|PMID=22258388
|Title=Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes
}}

{{PMID|17955236}} Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}